186 related articles for article (PubMed ID: 23496662)
1. Therapeutic vaccines and immunotherapies: current challenges and new frontiers.
Oviedo-Orta E; Plotkin SA; Ulmer JB; Ahmed SS
Expert Rev Vaccines; 2013 Mar; 12(3):243-4. PubMed ID: 23496662
[No Abstract] [Full Text] [Related]
2. Therapeutic vaccines for substance dependence.
Haney M; Kosten TR
Expert Rev Vaccines; 2004 Feb; 3(1):11-8. PubMed ID: 14761239
[TBL] [Abstract][Full Text] [Related]
3. Biotechnology and the treatment of addictive disorders: new opportunities.
Elkashef A; Biswas J; Acri JB; Vocci F
BioDrugs; 2007; 21(4):259-67. PubMed ID: 17628123
[TBL] [Abstract][Full Text] [Related]
4. Development of vaccines to help treat drug dependence.
Bunce CJ; Loudon PT; Akers C; Dobson J; Wood DM
Curr Opin Mol Ther; 2003 Feb; 5(1):58-63. PubMed ID: 12669472
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic vaccines for substance dependence.
Kosten TR; Biegel D
Expert Rev Vaccines; 2002 Oct; 1(3):363-71. PubMed ID: 12901575
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy: a 10-year anniversary issue.
Gregg M
Immunotherapy; 2019 Jan; 11(1):1-2. PubMed ID: 30702007
[No Abstract] [Full Text] [Related]
7. Vaccines and vaccine adjuvants as biological response modifiers.
Speil C; Rzepka R
Infect Dis Clin North Am; 2011 Dec; 25(4):755-72. PubMed ID: 22054754
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cell immunotherapy: mapping the way.
Figdor CG; de Vries IJ; Lesterhuis WJ; Melief CJ
Nat Med; 2004 May; 10(5):475-80. PubMed ID: 15122249
[TBL] [Abstract][Full Text] [Related]
9. Improving Vaccine and Immunotherapy Design Using Biomaterials.
Bookstaver ML; Tsai SJ; Bromberg JS; Jewell CM
Trends Immunol; 2018 Feb; 39(2):135-150. PubMed ID: 29249461
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy for the treatment of drug abuse.
Kosten T; Owens SM
Pharmacol Ther; 2005 Oct; 108(1):76-85. PubMed ID: 16023218
[TBL] [Abstract][Full Text] [Related]
11. 4th Australasian vaccines and immunotherapeutic development meeting.
Engwerda C; Belz G
Immunol Cell Biol; 2012 Nov; 90(10):921-4. PubMed ID: 23190698
[TBL] [Abstract][Full Text] [Related]
12. CTLA-4 blockade: autoimmunity as treatment.
Kapadia D; Fong L
J Clin Oncol; 2005 Dec; 23(35):8926-8. PubMed ID: 16204008
[No Abstract] [Full Text] [Related]
13. Combination strategies for enhancing the efficacy of immunotherapy in cancer patients.
Moschella F; Proietti E; Capone I; Belardelli F
Ann N Y Acad Sci; 2010 Apr; 1194():169-78. PubMed ID: 20536466
[TBL] [Abstract][Full Text] [Related]
14. New frontiers in cell-based immunotherapy of cancer.
D'Elios MM; Del Prete G; Amedei A
Expert Opin Ther Pat; 2009 May; 19(5):623-41. PubMed ID: 19441938
[TBL] [Abstract][Full Text] [Related]
15. Anti-drug vaccines to treat substance abuse.
Kinsey BM; Jackson DC; Orson FM
Immunol Cell Biol; 2009; 87(4):309-14. PubMed ID: 19333250
[TBL] [Abstract][Full Text] [Related]
16. [Vaccines for the treatment of drug addiction].
Zorzoli E; Marino MG; Bagnato B; Franco E
Ig Sanita Pubbl; 2016; 72(1):87-95. PubMed ID: 27077562
[TBL] [Abstract][Full Text] [Related]
17. A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting.
Gray A; Raff AB; Chiriva-Internati M; Chen SY; Kast WM
Immunol Rev; 2008 Apr; 222():316-27. PubMed ID: 18364011
[TBL] [Abstract][Full Text] [Related]
18. Vaccines against drugs of abuse: a viable treatment option?
Kantak KM
Drugs; 2003; 63(4):341-52. PubMed ID: 12558457
[TBL] [Abstract][Full Text] [Related]
19. [New dimensions for dendritic cells].
Hänninen A
Duodecim; 2014; 130(9):883-91. PubMed ID: 24881140
[TBL] [Abstract][Full Text] [Related]
20. Vaccines targeting tumor vasculature: a new approach for cancer immunotherapy.
Croix BS
Cytotherapy; 2007; 9(1):1-3. PubMed ID: 17354097
[No Abstract] [Full Text] [Related]
[Next] [New Search]
